Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 651-660 Newer>

Inc. November 1, 2002 Anne Stuart	High Concept: Miracle Tablets New rules covering medical data may create a market among M.D.'s for tablet PCs.
Bio-IT World November 12, 2002 Salvatore Salamone	Divide and Distribute Web services -- the hot new distributed computing architecture -- promise to help life science companies give their researchers, partners, and customers improved access to diverse applications and data.
Bio-IT World November 12, 2002 Davies et al.	John Craig Venter Unvarnished The former Celera CEO talks about that company's politics, the future of sequencing technology, and his own genome.
Bio-IT World November 12, 2002 Michael Gross	Biotronics: A Collision of Continents Biology and technology have evolved and merged to create the brave new world of biotronics.
Bio-IT World November 12, 2002 James Golden	The Business of Bioinformatics The industry has reached an interesting crossroads. As an academic branch of learning, bioinformatics remains mostly what it always was, a cross-disciplinary endeavor between computer science and molecular biology. But bioinformatics as a money-making proposition has different criteria for success.
Bio-IT World November 12, 2002 Debra Goldfarb	Disruption --The Real Revolution What is the real promise of the genomic revolution? It is its power to unleash disruptive innovation -- technology that allows a new group of people with different skill sets to do things in a decentralized, less expensive way.
Bio-IT World November 12, 2002 Andrew W. Torrance	After the Gene Rush About 20,000 gene-related patents have been granted in the U.S. so far, with twice as many on the way. The practical and political challenges are equally large.
Bio-IT World November 12, 2002 Paula Campbell Evans	Patently More Difficult The PTO has targeted gene patents with new application guidelines. Here's what they mean and how biotech companies can satisfy them.
Bio-IT World November 12, 2002 Beth E. Arnold	Navigating Gene Patent Minefields As the number of gene-related patents soars, so do the chances of patent infringement. Here are tips to avoid a costly misstep in this legal minefield.
Bio-IT World November 12, 2002 Sue Mayer	Are Gene Patents in the Public Interest? Two recent studies from Britain argue against the unbridled patenting of genes and raise tough ethical questions.
<Older 651-660 Newer> Return to current articles.